Paper Details 
Original Abstract of the Article :
Intranasal zaleplon solid dispersion was formulated to enhance the solubility, bioavailability and deliver an effective therapy. Zaleplon belongs to Class II drugs, and undergoes extensive first-pass metabolism after oral absorption exhibiting 30% bioavailability. A 2<sup>3</sup> full-factorial desi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/03639045.2017.1411941

データ提供:米国国立医学図書館(NLM)

Enhancing Drug Delivery to the Brain: A Journey Through the Nasal Passage

Delivering drugs to the brain, a fortress protected by a complex network of barriers, is a challenging task for researchers. This study explores the potential of intranasal zaleplon solid dispersion, a new delivery system, to bypass these barriers, offering a more effective way to deliver this sleep aid to the brain.

Navigating the Barriers to Brain Delivery

The researchers formulated intranasal zaleplon solid dispersion, a novel delivery system akin to building a bridge across a vast desert, to enhance the solubility, bioavailability, and effectiveness of this drug. They utilized a 23 full-factorial design to optimize the formulation, carefully considering various factors like drug to carrier ratio, carrier type, and preparation method.

A New Path to Improved Sleep

The study's findings demonstrate the potential of intranasal zaleplon solid dispersion to enhance the delivery of this sleep aid to the brain, potentially offering a more effective treatment option for insomnia. It's a glimpse into a future where innovative drug delivery systems can overcome the barriers of the brain, providing new pathways to treat a wide range of conditions.

Dr. Camel's Conclusion

This research offers a promising new approach to drug delivery, akin to discovering a hidden oasis in the vast desert of the brain. The potential of intranasal zaleplon solid dispersion to enhance the effectiveness of this sleep aid provides a glimmer of hope for individuals struggling with insomnia. It's a testament to the ongoing quest for better and more efficient ways to deliver medications, a journey that could revolutionize the treatment of various neurological conditions.
Date :
  1. Date Completed 2018-10-01
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

29235903

DOI: Digital Object Identifier

10.1080/03639045.2017.1411941

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.